Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Nelson

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
Molecular Pain|October 22, 2011
Inhibition of p38-MAPK signaling pathway attenuates breast cancer induced bone pain and disease progression in a murine model of cancer-induced bone painDevki Sukhtankar, Alec Okun, Anupama Chandramouli, et al.
Carcinogenesis|March 29, 2007
Haploinsufficiency of the cdc2l gene contributes to skin cancer development in miceAnupama Chandramouli, Jiaqi Shi, Yongmei Feng, et al.
Neurobiology of Disease|July 26, 2019
TAF1-gene editing alters the morphology and function of the cerebellum and cerebral cortexUdaiyappan Janakiraman, Jie Yu, Aubin Moutal, et al.
Academic Pathology|July 21, 2017
Flexner 2.0-Longitudinal Study of Student Participation in a Campus-Wide General Pathology Course for Graduate Students at The University of ArizonaMargaret M Briehl, Mark A Nelson, Elizabeth A Krupinski, et al.
Epigenetics|November 29, 2019
DNA methylation biomarkers discovered <i>in silico</i> detect cancer in liquid biopsies from non-small cell lung cancer patientsLukas Vrba, Marc M Oshiro, Samuel S Kim, et al.
International Journal of Cancer|June 28, 2007
Identification of Fn14/TWEAK receptor as a potential therapeutic target in esophageal adenocarcinomaGeorge S Watts, Nhan L Tran, Michael E Berens, et al.
Experimental Cell Research|July 17, 2007
The EP4 receptor antagonist, L-161,982, blocks prostaglandin E2-induced signal transduction and cell proliferation in HCA-7 colon cancer cellsDurga Prasad Cherukuri, Xiao B O Chen, Anne-Christine Goulet, et al.
Cancer Biology & Therapy|February 23, 2012
MicroRNA-101 (miR-101) post-transcriptionally regulates the expression of EP4 receptor in colon cancersAnupama Chandramouli, Benjamin Chidi Onyeagucha, Melania E Mercado-Pimentel, et al.
Cancer Biology & Therapy|December 23, 2003
Analysis of cyclooxygenase 2 (COX-2) expression during malignant melanoma progressionA-C Goulet, Janine G Einsphar, David S Alberts, et al.
Breast Cancer (Dove Medical Press)|May 18, 2016
Modulation of breast cancer cell viability by a cannabinoid receptor 2 agonist, JWH-015, is calcium dependentKatherine E Hanlon, Alysia N Lozano-Ondoua, Puja J Umaretiya, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Molecular Pain|October 22, 2011
Inhibition of p38-MAPK signaling pathway attenuates breast cancer induced bone pain and disease progression in a murine model of cancer-induced bone painDevki Sukhtankar, Alec Okun, Anupama Chandramouli, et al.
Carcinogenesis|March 29, 2007
Haploinsufficiency of the cdc2l gene contributes to skin cancer development in miceAnupama Chandramouli, Jiaqi Shi, Yongmei Feng, et al.
Neurobiology of Disease|July 26, 2019
TAF1-gene editing alters the morphology and function of the cerebellum and cerebral cortexUdaiyappan Janakiraman, Jie Yu, Aubin Moutal, et al.
Academic Pathology|July 21, 2017
Flexner 2.0-Longitudinal Study of Student Participation in a Campus-Wide General Pathology Course for Graduate Students at The University of ArizonaMargaret M Briehl, Mark A Nelson, Elizabeth A Krupinski, et al.
Epigenetics|November 29, 2019
DNA methylation biomarkers discovered <i>in silico</i> detect cancer in liquid biopsies from non-small cell lung cancer patientsLukas Vrba, Marc M Oshiro, Samuel S Kim, et al.
International Journal of Cancer|June 28, 2007
Identification of Fn14/TWEAK receptor as a potential therapeutic target in esophageal adenocarcinomaGeorge S Watts, Nhan L Tran, Michael E Berens, et al.
Experimental Cell Research|July 17, 2007
The EP4 receptor antagonist, L-161,982, blocks prostaglandin E2-induced signal transduction and cell proliferation in HCA-7 colon cancer cellsDurga Prasad Cherukuri, Xiao B O Chen, Anne-Christine Goulet, et al.
Cancer Biology & Therapy|February 23, 2012
MicroRNA-101 (miR-101) post-transcriptionally regulates the expression of EP4 receptor in colon cancersAnupama Chandramouli, Benjamin Chidi Onyeagucha, Melania E Mercado-Pimentel, et al.
Cancer Biology & Therapy|December 23, 2003
Analysis of cyclooxygenase 2 (COX-2) expression during malignant melanoma progressionA-C Goulet, Janine G Einsphar, David S Alberts, et al.
Breast Cancer (Dove Medical Press)|May 18, 2016
Modulation of breast cancer cell viability by a cannabinoid receptor 2 agonist, JWH-015, is calcium dependentKatherine E Hanlon, Alysia N Lozano-Ondoua, Puja J Umaretiya, et al.
Pageof 6